Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2021

Open Access 01.12.2021 | Research article

Cross-cultural adaptation, reliability, and validity of a Chinese version of the pelvic girdle questionnaire

verfasst von: Hui Cong, Heng Liu, Yin Sun, Jinsong Gao, Juntao Liu, Liangkun Ma, Britt Stuge, Lixia Chen

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2021

Abstract

Background

The Pelvic Girdle Questionnaire (PGQ) is the only specific instrument designed to evaluate pain and activity limitations in pregnant or postpartum women with pelvic girdle pain (PGP). This study aimed to translate and culturally adapt the PGQ for Chinese patients and to verify the validation of the psychometric items of the PGQ in the Chinese population.

Methods

First, the translation and cultural adaptation process of the PGQ was conducted on the basis of international guidelines. Eighteen women suffering from PGP (11 pregnant women and 7 postpartum women) were enrolled in the pilot tests. Second, a total of 130 pregnant and postpartum women with PGP were enrolled to evaluate the validation of the psychometric items of the Chinese version.

Results

The calculated Cronbach’s alphas demonstrated a high level of internal consistency for the Chinese version of the PGQ, ranging from 0.77 to 0.93. The convergent validity showed a high positive correlation between the PGQ total score and the Oswestry Disability Index (0.84) and Numeric Rating Scale (0.73) for pain intensity. Furthermore, a good discriminatory ability was found for the Chinese version of the PGQ for distinguishing women who needed treatment from those not (area under the curve [AUC] = 0.843, p < 0.001), but not for discriminating the pregnant and postpartum states (AUC = 0.488, p = 0.824). The results of test–retest showed good reproducibility for the total PGQ (ICC = 0.93), the PGQ activity subscale (ICC = 0.92), and the PGQ symptom subscale (ICC = 0.77).

Conclusion

Our study presents the translation, validation and psychometric features of the Chinese version of the PGQ, showing good construct validity and discriminative power for assessing the consequences of PGP among pregnant or postpartum Chinese women.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12884-021-03962-8.
Hui Cong and Heng Liu contributed equally to this work.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
PGQ
Pelvic Girdle Questionnaire
PGP
Pelvic girdle pain
ICC
Intraclass correlation coefficient
SEM
Standard error of measurement

Background

Pelvic girdle pain (PGP) is a common pain during or after pregnancy, characterized by the presence of pain between the posterior iliac crest and the gluteal fold, particularly around the sacroiliac joints [13]. It is reported that approximately 45% of pregnant women and 25% of postpartum women suffer from PGP worldwide [4]. PGP severely interferes with the activities of daily living for pregnant and postpartum women [5]. The average sick leave for women with PGP during pregnancy or after pregnancy ranges from 7–12 weeks [6], resulting in huge economic costs. Thus, PGP should be given close attention in clinical practice.
The Oswestry disability index (ODI) and the Numeric Rating Scale (NRS) for pain intensity are the most common disability tools applied to evaluate PGP [711]. However, these questionnaires were originally developed for people with low back pain (LBP) and are not condition-specific measures for PGP [12, 13]. The Pelvic Girdle Questionnaire (PGQ) is the only instrument developed specifically for assessing PGP in pregnant or postpartum women [1416]. Due to differences in language and cultural environment, patients from different countries will have different understandings of the PGQ items, leading to deviations in evaluation effectiveness [16, 17]. Therefore, it is best to translate the original PGQ into the corresponding language version as required. Currently, English, Norwegian, French, Iranian, Swedish, and Spanish versions of the PGQ are available [1622].
As China is the most populous country in the world, a considerable number of pregnant women suffer from PGP every year in China. However, there is currently no standard treatment for these women in China. Thus, in many cases, timely and effective treatment cannot be given to women with PGP who really need treatment [23]. Previous studies have found that the original PGQ and the translated PGQ versions can effectively distinguish between PGP patients who need treatment and those who do not [17, 19]. However, to the best of our knowledge, a Chinese version of the PGQ that can be used in clinical practice has not been developed yet. Therefore, we conducted the present study to translate and culturally adapt the PGQ for Chinese patients and to assess its construct validity and discriminative ability in a Chinese population.

Methods

This research project was divided into two parts. In the initial part, the translation and cross-cultural adaptation procedures for the PGQ were conducted on the basis of international guidelines [24]. A total of 18 women with PGP were included in the pilot tests to assess the prefinal Chinese version of the PGQ in both pregnant women (n = 11) and postpartum women (n = 7). In the second part, a group of 130 pregnant or postpartum women suffering from PGP were used to validate the psychometric features of the Chinese version of the PGQ (Fig. 1). The Questionnaires were self-answered by all participants while in the hospital.

Instruments

The PGQ is a simple instrument consisting of 25 items, including 20 items that assess activity limitations (activity subscale) and 5 items that evaluate symptoms (symptom subscale) [14]. Each item has 4 points and is scored using a Likert-type scale ranging from 0 to 3. The maximum possible score for the PGQ is 75, including 60 for the activity subscale and 15 for the symptom subscale. For an item without an answer or with a response of “not applicable”, three points are subtracted from the total possible score. The final data are presented as a percentage ranging from 0 (without disability) to 100 (severe disability). A higher score indicates a worse outcome.
The ODI (2.0 version) is one of the most commonly used tools in clinical practice for assessment of low back pain [11, 25]. Thus, we applied this instrument in our study to serve as a possible control in analyzing the relevance of the PGQ and ODI. This scale has 10 items, including pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sexual life, social life and traveling. Each item has six response categories, ranging from 0 to 5 points [25]. The final data are divided into five categories (without disability, moderate disability, severe disability, crippled, and bedbound or exaggerating their symptoms) presented as a percentage score ranging from 0–100% with a 20% interval.
The 11-point NRS (0–10) is a tool commonly used to measure pain intensity [19]. It is labeled from 0 to 10, with 0 representing no pain and 10 reflecting the worst pain possible.

Translation and cross-cultural adaptation

Approval was obtained from one of the authors of the original questionnaire before the translation process was started. The translation of the English version of the PGQ into Chinese was completed according to a 5-stage approach based on the guidelines for translation and cultural adaptation of questionnaires [26]. The detailed steps are as follows. The English version of the PGQ was independently translated into Chinese by two native Chinese speakers with a good command of English. Neither of the translators were previously familiar with the PGQ or PGP. One of the two translators was an orthopedic surgeon, and the other was a physiatrist. After translation, the two translated PGQs (Chinese versions) were compared with each other and synthesized, and then compared with the English version. Meanwhile, the synthesized Chinese version was conversely translated into English by two native English speakers independently. Both English translators, a professional translator and a physiotherapist, were not familiar with the original instrument before translation. After that, the two English translators were then introduced to the PGQ. A back-translation version (English) was obtained after an expert committee discussed the translations and resolved discrepancies. Experts proficient in psychometry, linguistics and PGP were included in this expert committee. For the purpose of capturing the accurate meaning of each item, the committee could refer back to the original Chinese version when difficulties were encountered in translations. A total of 18 women with PGP (11 pregnant women and 7 postpartum women) were enrolled to evaluate the prefinal version of the Chinese version of the PGQ. All the participants were required to explain the meaning of each point in the questionnaire and to describe any difficulty they experienced in understanding the question or statement. In addition, the participants were asked to reflect on the relevance of each item in the PGQ to their PGP situation. The women were asked to re-state the item if they encountered difficulties. Finally, all inconsistencies and difficulties were discussed until a consensus was reached by the expert committee.

Validation

A total of 151 women suffering from PGP and attending our hospital were recruited for the second part of the study. All of the participants were clinically examined and confirmed to have PGP based on the recommendations from the European guidelines [24]. All the participants were enrolled from May 2019 to January 2020. Twenty-one participants were removed from the study because they did not complete the PGQ (missing items were found after the PGQ was collected). Finally, 130 participants were included in this study, and 67 of the included participants completed the PGQ again within 7 days. These data were used to evaluate the test–retest reliability. None of the patients enrolled in this study received any treatment for PGP.
The inclusion and exclusion criteria for the study were: PGP presenting in pregnancy or within 3 weeks after delivery; pain between the posterior iliac crest and the gluteal fold, particularly in the vicinity of the sacroiliac joint; pain radiating in the posterior thigh and also occurring in conjunction with/or separately from the symphysis; positive result on posterior pelvic pain provocation test and active straight leg raise test; positive result on the long dorsal sacroiliac ligament (LDL) test or symphysis pain palpation test, or positive for pain provocation of the symphysis by Modified Trendelenburg’s test; absence of hip disease, spondylolisthesis, lumbar disease or any autoimmune disease; no prior surgery related to the spine, pelvis or lower limbs; absence of radicular pain below the knee; absence of urinary disease; and absence of neurosensory disorders. Patients who met all the above criteria were diagnosed with PGP.

Construct validity

The construct validity was calculated to test the extent to which scores on the Chinese version of the PGQ related to the theoretical concept of disability in women with PGP. The method reported by Annelie et al. was used to assess the divergent and convergent evidence of the construct validity [19], including five hypotheses: i) high correlation between the scores on the ODI and the activity subscale of the Chinese version of the PGQ; ii) moderate correlation between the scores on the ODI and the symptom subscale of the Chinese version of the PGQ; iii) high correlation between the scores for pain intensity and the total score on the Chinese version of the PGQ; iv) high correlation between the scores for pain intensity and the symptom subscale of the Chinese version of the PGQ; and v) moderate correlation between the scores on the NRS and the total score on the Chinese version of the PGQ.

Discriminative validity

The area under the receiver operating characteristic (ROC) curve (AUC) was computed to evaluate the discriminative validity of the instrument for the following two aspects. First, the ROC curve was used to discriminate women with treatment or treatment needs reported in the instrument from women without treatment needs. Second, the ROC curve was applied to distinguish women during pregnancy from women in the postpartum period.

Test–retest reliability

To further confirm the reliability of the questionnaire, 67 patients were asked to complete the questionnaire twice within 7 days. The intraclass correlation coefficient (ICC) was calculated to assess the sensitivity and reproducibility of the test. An ICC value greater than 0.80 indicated satisfactory reproducibility [27, 28]. The standard error of measurement (SEM) was also calculated based on the ICC value and its standard deviation using a previously reported formula [29, 30].

Statistical analyses

Spearman’s correlation coefficients were computed to assess the association between the PGQ and ODI or NRS. Values less than 0.3 indicate low correlation; values from 0.3 to 0.6 indicate moderate correlation; and values greater than 0.6 indicate high correlation [19]. The internal consistency was computed using Cronbach’s alphas, and values ranging from 0.7 to 0.95 implied a good internal consistency. ROC curve analysis was performed to evaluate the discriminative ability of the Chinese PGQ. All statistical analyses were conducted using SPSS software (version 22.0, SPSS, Inc., Chicago, IL, USA). All results are presented as mean values with standard deviations.

Ethical approval

All procedures conducted in this study involving human participants complied with the ethical standards of the Handbook for Good Clinical Research Practice of the World Health Organization and the Declaration of Helsinki principles (https://​www.​wma.​net/​policies-post/​wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/​).

Results

Translation and cross-cultural adaptation

The final analysis included 80 pregnant women (61.5%) and 50 postpartum women (38.5%). The mean age of these women was 32.2 years (SD 3.7 years), and the average gestational age in weeks was 29.7 (SD 8.1). One hundred twenty-five (96.2%) patients had a bachelor’s degree or higher. The detailed characteristics of the participants enrolled in the second part of this study are presented in Table 1. In general, most participants considered the items of the Chinese version of the PGQ to be concise, easy to understand, and strongly relevant to the symptoms of PGP. Two participants considered it hard to correctly understand the introductory text, the 16th item “Carry out sporting activities”, and the 19th item “Have a normal sex life”. Four participants had difficulties in correctly interpreting the meaning of the 23th item “Has your leg/have your legs given way”.
Table 1
Characteristics of participants enrolled in the validation portion (second part) of the study (n = 130)
Characteristic
 
Pregnant
80(61.5%)
 Gestational weeks
29.7(SD 8.1) (6–39)
Postpartum
50(38.5%)
 Postpartum weeks
7.7(SD 5.4) (1–21)
Parity
 0
53(40.8%)
 1
64(49.2%)
 2
13(8.4%)
Age, years
32.2(SD 3.7) (23–40)
Body mass index, kg/m2
24.2(SD 2.5) (17.6–31.1)
Education
 High school diploma
5 (3.8%)
 Bachelor’s degree
72 (55.4%)
 Postgraduate degree
53 (40.8%)
PGQ total score
39.8 (SD 18.0) (5.3–81.9)
PGQ activity score
39.9 (SD 18.7) (5.0–84.2)
PGQ symptom score
39.8 (SD 17.4) (6.7–86.7)
ODI score
29.8 (SD 11.4) (8–56)
NRS score
3.9 (SD 1.8) (1–8)
PGQ Pelvic Girdle Questionnaire, ODI Oswestry Disability Index, NRS Numeric Rating Scale, SD standard deviation

Validation

None of the tools included in this study showed ceiling or floor effects for either the total score or subscales scores of the PGQ. Eighteen women chose not applicable for the 16th item “Carry out sporting activities”, and 18 women chose not applicable for the 19th item “Have a normal sex life”. Thirty-four women did not provide an answer for the item about sex in the ODI.
The correlations among the Chinese version of the PGQ, ODI, and NRS for pain intensity are presented in detail in Table 2. The correlation coefficients for the relationships between the PGQ total score and ODI and NRS scores were 0.84 and 0.73, respectively. In addition, high correlations were found between the PGQ activity and symptom scores and the ODI score (0.82 and 0.71, respectively) and NRS score (0.80 and 0.72, respectively; Table 2). For the construct validity of the translated PGQ, five formulated hypotheses were evaluated, and four of them were confirmed: PGQ total to ODI, PGQ activity subscale to ODI, PGQ total to NRS, and PGQ symptom subscale to NRS (Table 3). For the discriminative validity of the translated PGQ, the results from ROC curve analysis showed that the Chinese version of the PGQ could significantly distinguish pregnant/postpartum women with PGP who received or requested treatment from those who do not need treatment (Fig. 2, Table 4). The AUC values for the PGQ total score, activity subscale score and symptom subscale score ranged from 0.772–0.918 (p < 0.001). The sensitivity and specificity of the translated PGQ for correctly predicting treatment and non-treatment were 0.57–0.70 and 0.82–0.97, respectively. However, the ROC curve analysis showed no significant discriminative ability of the PDQ for distinguishing pregnant women and postpartum women with PGP (Supplementary Table 1).
Table 2
Spearman’s correlation analysis among the pelvic girdle questionnaire, oswestry disability index and numeric rating scale (n = 130)
 
PGQ total
PGQ activity
PGQ symptom
ODI
NRS
PGQ total
1
    
PGQ activity
0.99
1
   
PGQ symptom
0.89
0.84
1
  
ODI
0.84
0.82
0.80
1
 
NRS
0.73
0.71
0.72
0.67
1
Note: PGQ Pelvic Girdle Questionnaire, ODI Oswestry Disability Index, NRS Numeric Rating Scale
Table 3
Five a priori formulated hypotheses and correlation coefficients values for construct validity (n = 130)
Hypothesis
Instruments compared
Spearman’s correlation coefficient
Hypothesis confirmed?
High correlation between PGQ total score and ODI
PGQ total-ODI
0.84
Yes
High correlation between PGQ activity subscale and ODI
PGQ activity subscale-ODI
0.82
Yes
Moderate correlation between PGQ symptom subscale and ODI
PGQ symptom subscale-ODI
0.80
NO
High correlation between PGQ total score and NRS
PGQ total-NRS
0.73
Yes
High correlation between PGQ symptom subscale and NRS
PGQ symptom subscale-NRS
0.72
Yes
Note: PGQ Pelvic Girdle Questionnaire, ODI Oswestry Disability Index, NRS Numeric Rating Scale
Table 4
Comparison of instrument scores according to received or requested treatment by ROC curve analysis
 
Value
n(%) of events
OR (95% CI)
Univariate logistic regression analysis p-value
AUC (95%CI)
p value
PGQ total score
(OR per 5 units)
5- < 29
29–43
43 < 82
16 (40.0)
30 (68.2)
45 (97.8)
1.75 (1.40–2.20)
 < 0.001
0.843(0.778–0.909)
 < 0.001
PGQ activity score
(OR per 5 units)
5- < 29
29–45
45- < 84
18 (40.0)
28 (71.8)
45 (97.8)
1.65 (1.35–2.02)
 < 0.001
0.839(0.772–0.906)
 < 0.001
PGQ symptom score
(OR per 5 units)
6–30
30- < 40
40–86
13 (35.1)
30 (71.4)
48 (94.1)
1.79 (1.43–2.24)
 < 0.001
0.845(0.772–0.918)
 < 0.001
For the factor analysis, the Kaiser–Meyer–Olkin value was 0.824 and the p value of the Bartlett sphericity test was less than 0.001. A forced solution with three components was rotated using the Varimax method (Supplementary Table 2, Supplementary Figure 1).

Test–retest reliability

Test–retest reliability was calculated with a random sub-sample of 67 patients who repeated the Chinese version of the PGQ after 1 week. The result of the internal consistency test showed satisfactory reproducibility (ICC > 0.77) for the total PGQ (ICC = 0.93), the PGQ activity subscale (ICC = 0.92), and the PGQ symptom subscale (ICC = 0.77) (Table 5). The SEM was 3.94%, indicating a low discrepancy between the results of a particular evaluation and the average of all the results hypothetically possible for a patient.
Table 5
Internal consistency for the instruments of the PGQ
 
Number of women with missing data
All women, mean (SD)
Cronbach’s alpha
PGQ total
  
0.93
PGQ activity
  
0.92
1. Dress yourself
0
0.55(0.81)
 
2. Stand for less than 10 min
0
0.43(0.70)
 
3. Stand for more than 60 min
0
1.72(0.95)
 
4. Bend down
0
1.60(0.89)
 
5. Sit for less than 10 min
0
0.38(0.77)
 
6. Sit for more than 60 min
0
1.50(0.97)
 
7. Walk for less than 10 min
0
0.59(0.78)
 
8. Walk for more than 60 min
0
1.79(0.91)
 
9. Climb stairs
0
1.29(0.90)
 
10. Do housework
0
1.22(0.84)
 
11. Carry light objects
0
0.78(0.76)
 
12. Carry heavy objects
0
2.10(0.85)
 
13. Get up/sit down
0
1.10(0.96)
 
14. Push a shopping cart
0
0.41(0.67)
 
15. Run
0
1.72(1.01)
 
16. Carry out sporting activities
18
1.84(.092)
 
17. Lie down
0
0.98(0.98)
 
18. Roll over in bed
0
1.72(1.06)
 
19. Have a normal sex life
34
1.05(0.97)
 
20. Push something with 1 foot
0
1.14(0.86)
 
PGQ symptom
  
0.77
21. Pain in the morning
0
1.12(0.77)
 
22. Pain in the evening
0
1.65(0.72)
 
23. Has your leg/have your legs given way?
0
0.83(0.74)
 
24. Do you do things more slowly?
0
1.52(0.75)
 
25. Is your sleep interrupted?
0
0.85(0.81)
 
Note: PGQ Pelvic Girdle Questionnaire

Discussion

The aim of this study was to verify the transcultural adaptation and validation of the Chinese version of the PGQ. The results show that the Chinese version of the PGQ is easily accepted among women with PGP and presented good validation in terms of construction and discrimination of PGQ in China. Furthermore, good internal consistency and high reliability were verified for the Chinese version PGQ in the test–retest analysis.
The Chinese version of the PGQ shows similar construct validity to the original Norwegian version [22], as well as the translated Swedish version [19]. The present study shows lower internal consistency for the total scale compared with the Spanish translation (0.96) [17] and the Sweden translation (0.96) [19]. However, a consistency coefficient greater than 0.95 is considered indicative of redundancy among questionnaire items [27]. This demonstrates that all the items in the Chinese version of the PGQ are required as are those in the original Norwegian version.
In the study by Annelie et al., the Swedish version of the PGQ showed discriminatory ability between treatment and non-treatment pregnant/postpartum women with PGP [19]. Similarly, our results for discriminative validity indicate that the Chinese version of the PGQ could also effectively distinguish pregnant/postpartum women with PGP who need treatment from those who do not need treatment. This finding has important clinical implications for determining the need for intervention among Chinese women with PGP. This Chinese version of the PGQ can be used to effectively identify the PGP patients who need treatment in clinical practice. Thus, timely treatment can be given to such patients, avoiding continuous deterioration and improving their daily life [31, 32].
The original PGQ has been reported to have discriminatory power for separating pregnant women from postpartum women [22]. However, no significant difference was found in the AUC values for the translated PGQ for distinguishing between pregnant women and postpartum women with PGP, which is similar to the result for the Spanish version of the PGQ [17]. The possible reasons for this inconsistent result are the different educational backgrounds and parity of the patients [33]. The parity of most participants (91.6%) was 0 or 1 in the present study and 2 for only 13 women.
To confirm the reliability of the Chinese version of the PGQ, we performed a re-test of the PGQ on a random sub-sample of 67 patients who repeated the PGQ within 1 week. A high level of consistency was observed for the total score, the activity subscale score and the symptom subscale score, as indicated by the ICC values, representing the high reliability and stability of the Chinese version of the PGQ. Similar results were obtained for the Spanish version of the PGQ [17]. Further studies involved in translation of the PGQ are recommended to include the test–retest step in the validation to strengthen the evidence of the reliability of the translated PGQ.
Some limitations of this study should be considered. First, only 130 patients were included in this study to verify the cultural adaptation, reliability, and validity of the Chinese version of the PGQ, and most (96.2%) had a bachelor’s degree or a higher degree. Because most Chinese women only have a high school education [34], further research with a larger sample containing more women with only a high school education is required to confirm the reliability of the Chinese version of the PGQ for the general Chinese population. Second, the diagnosis of PGP in this study was mainly based on clinical tests. Because no statistical analysis was performed on the data from these clinical tests, we could not conduct a correlation analysis between clinical test results and scores on the Chinese version of PGQ. Finally, because only 151 women were included in this study, this study may have been underpowered from a statistical perspective.

Conclusions

In summary, the Chinese version of the PGQ was found to be linguistically accurate, valid with high internal consistency, reliable and understandable for the evaluation of PGP disability among women both during and after pregnancy. The Chinese version of the PGQ showed a good ability to discriminate women who need treatment from women without a reported need for treatment. The use of this Chinese version of the PGQ will effectively improve the clinical care and research related to PGP in Chinese-speaking populations, promoting international research and decision-making based on common references.

Acknowledgements

Not applicable

Declarations

All procedures conducted in this study involving human participants complied with the ethical standards of the Handbook for Good Clinical Research Practice of the World Health Organization and the Declaration of Helsinki principles (https://​www.​wma.​net/​policies-post/​wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/​). The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Institutional Review Board (IRB) of Peking Union Medical College Hospital (PUMCH), China. Written informed consent was obtained from all subjects.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Cooper T. Top ten tips for women experiencing pelvic pain in pregnancy Tasha Cooper. Essentially Midirs. 2013;4:27–31. Cooper T. Top ten tips for women experiencing pelvic pain in pregnancy Tasha Cooper. Essentially Midirs. 2013;4:27–31.
2.
Zurück zum Zitat Bertuit J, Van Lint CE, Rooze M, Feipel V. Pregnancy and pelvic girdle pain: analysis of pelvic belt on pain. J Clin Nurs. 2018;27:e129–37.CrossRef Bertuit J, Van Lint CE, Rooze M, Feipel V. Pregnancy and pelvic girdle pain: analysis of pelvic belt on pain. J Clin Nurs. 2018;27:e129–37.CrossRef
3.
Zurück zum Zitat Vermani E, Mittal R, Weeks A. Pelvic girdle pain and low back pain in pregnancy: a review. Pain Pract. 2010;10:60–71.CrossRef Vermani E, Mittal R, Weeks A. Pelvic girdle pain and low back pain in pregnancy: a review. Pain Pract. 2010;10:60–71.CrossRef
4.
Zurück zum Zitat Wu W-H, Meijer OG, Uegaki K, Mens J, Van Dieen J, Wuisman P, et al. Pregnancy-related pelvic girdle pain (PPP), I: terminology, clinical presentation, and prevalence. Eur Spine J. 2004;13:575–89.CrossRef Wu W-H, Meijer OG, Uegaki K, Mens J, Van Dieen J, Wuisman P, et al. Pregnancy-related pelvic girdle pain (PPP), I: terminology, clinical presentation, and prevalence. Eur Spine J. 2004;13:575–89.CrossRef
5.
Zurück zum Zitat Elden H, Lundgren I, Robertson E. The pelvic ring of pain: pregnant women’s experiences of severe pelvic girdle pain: an interview study. Clin Nurs Stud. 2014;2:2. Elden H, Lundgren I, Robertson E. The pelvic ring of pain: pregnant women’s experiences of severe pelvic girdle pain: an interview study. Clin Nurs Stud. 2014;2:2.
6.
Zurück zum Zitat Norén L, Ostgaard S, Nielsen TF, Ostgaard HC. Reduction of sick leave for lumbar back and posterior pelvic pain in pregnancy. Spine. 1997;22:2157–60.CrossRef Norén L, Ostgaard S, Nielsen TF, Ostgaard HC. Reduction of sick leave for lumbar back and posterior pelvic pain in pregnancy. Spine. 1997;22:2157–60.CrossRef
7.
Zurück zum Zitat Kuciel N, Sutkowska E, Cienska A, Markowska D, Wrzosek Z. Impact of Kinesio Taping application on pregnant women suffering from pregnancy-related pelvic girdle pain—preliminary study. Ginekol Pol. 2017;88:620–5.CrossRef Kuciel N, Sutkowska E, Cienska A, Markowska D, Wrzosek Z. Impact of Kinesio Taping application on pregnant women suffering from pregnancy-related pelvic girdle pain—preliminary study. Ginekol Pol. 2017;88:620–5.CrossRef
8.
Zurück zum Zitat Gausel AM, Kjærmann I, Malmqvist S, Dalen I, Larsen JP, Økland I. Pelvic girdle pain 3–6 months after delivery in an unselected cohort of Norwegian women. Eur Spine J. 2016;25:1953–9.CrossRef Gausel AM, Kjærmann I, Malmqvist S, Dalen I, Larsen JP, Økland I. Pelvic girdle pain 3–6 months after delivery in an unselected cohort of Norwegian women. Eur Spine J. 2016;25:1953–9.CrossRef
9.
Zurück zum Zitat Vøllestad NK, Stuge B. Prognostic factors for recovery from postpartum pelvic girdle pain. Eur Spine J. 2009;18:718–26.CrossRef Vøllestad NK, Stuge B. Prognostic factors for recovery from postpartum pelvic girdle pain. Eur Spine J. 2009;18:718–26.CrossRef
10.
Zurück zum Zitat Gausel AM, Malmqvist S, Andersen K, Kjærmann I, Larsen JP, Dalen I, et al. Subjective recovery from pregnancy-related pelvic girdle pain the first 6 weeks after delivery: a prospective longitudinal cohort study. Eur Spine J. 2020;29:556–63.CrossRef Gausel AM, Malmqvist S, Andersen K, Kjærmann I, Larsen JP, Dalen I, et al. Subjective recovery from pregnancy-related pelvic girdle pain the first 6 weeks after delivery: a prospective longitudinal cohort study. Eur Spine J. 2020;29:556–63.CrossRef
11.
Zurück zum Zitat Franke H, Franke J-D, Belz S, Fryer G. Osteopathic manipulative treatment for low back and pelvic girdle pain during and after pregnancy: a systematic review and meta-analysis. J Bodyw Mov Ther. 2017;21:752–62.CrossRef Franke H, Franke J-D, Belz S, Fryer G. Osteopathic manipulative treatment for low back and pelvic girdle pain during and after pregnancy: a systematic review and meta-analysis. J Bodyw Mov Ther. 2017;21:752–62.CrossRef
12.
Zurück zum Zitat Chiarotto A, Maxwell LJ, Ostelo RW, Boers M, Tugwell P, Terwee CB. Measurement properties of visual analogue scale, numeric rating scale, and pain severity subscale of the brief pain inventory in patients with low back pain: a systematic review. J Pain. 2019;20:245–63.CrossRef Chiarotto A, Maxwell LJ, Ostelo RW, Boers M, Tugwell P, Terwee CB. Measurement properties of visual analogue scale, numeric rating scale, and pain severity subscale of the brief pain inventory in patients with low back pain: a systematic review. J Pain. 2019;20:245–63.CrossRef
13.
Zurück zum Zitat Yakut E, Düger T, Öksüz Ç, Yörükan S, Üreten K, Turan D, et al. Validation of the Turkish version of the Oswestry Disability Index for patients with low back pain. Spine. 2004;29:581–5.CrossRef Yakut E, Düger T, Öksüz Ç, Yörükan S, Üreten K, Turan D, et al. Validation of the Turkish version of the Oswestry Disability Index for patients with low back pain. Spine. 2004;29:581–5.CrossRef
14.
Zurück zum Zitat Stuge B, Garratt A, Krogstad Jenssen H, Grotle M. The pelvic girdle questionnaire: a condition-specific instrument for assessing activity limitations and symptoms in people with pelvic girdle pain. Phys Ther. 2011;91:1096–108.CrossRef Stuge B, Garratt A, Krogstad Jenssen H, Grotle M. The pelvic girdle questionnaire: a condition-specific instrument for assessing activity limitations and symptoms in people with pelvic girdle pain. Phys Ther. 2011;91:1096–108.CrossRef
15.
Zurück zum Zitat Stuge B, Jenssen HK, Grotle M. The pelvic girdle questionnaire: responsiveness and minimal important change in women with pregnancy-related pelvic girdle pain, low back pain, or both. Phys Ther. 2017;97:1103–13.PubMed Stuge B, Jenssen HK, Grotle M. The pelvic girdle questionnaire: responsiveness and minimal important change in women with pregnancy-related pelvic girdle pain, low back pain, or both. Phys Ther. 2017;97:1103–13.PubMed
16.
Zurück zum Zitat Girard M-P, Marchand A-A, Stuge B, Ruchat S-M, Descarreaux M. Cross-cultural adaptation of the pelvic girdle questionnaire for the french-canadian population. J Manipulative Physiol Ther. 2016;39:494–9.CrossRef Girard M-P, Marchand A-A, Stuge B, Ruchat S-M, Descarreaux M. Cross-cultural adaptation of the pelvic girdle questionnaire for the french-canadian population. J Manipulative Physiol Ther. 2016;39:494–9.CrossRef
17.
Zurück zum Zitat Rejano-Campo M, Ferrer-Peña R, Urraca-Gesto MA, Gallego-Izquierdo T, Pecos-Martín D, Stuge B, et al. Transcultural adaptation and psychometric validation of a Spanish-language version of the “pelvic girdle questionnaire.” Health Qual Life Outcomes. 2017;15:1–9.CrossRef Rejano-Campo M, Ferrer-Peña R, Urraca-Gesto MA, Gallego-Izquierdo T, Pecos-Martín D, Stuge B, et al. Transcultural adaptation and psychometric validation of a Spanish-language version of the “pelvic girdle questionnaire.” Health Qual Life Outcomes. 2017;15:1–9.CrossRef
18.
Zurück zum Zitat Fakari FR, Kariman N, Ozgoli G, Naz MSG, Ghasemi V, Fakari FR, et al. Iranian version of pelvic girdle questionnaire: psychometric properties and cultural adaptation. J Res Med Sci. 2019;24:43.CrossRef Fakari FR, Kariman N, Ozgoli G, Naz MSG, Ghasemi V, Fakari FR, et al. Iranian version of pelvic girdle questionnaire: psychometric properties and cultural adaptation. J Res Med Sci. 2019;24:43.CrossRef
19.
Zurück zum Zitat Gutke A, Stuge B, Elden H, Sandell C, Asplin G, Fagevik OM. The Swedish version of the pelvic girdle questionnaire, cross-cultural adaptation and validation. Disabil Rehabil. 2020;42:1013–20.CrossRef Gutke A, Stuge B, Elden H, Sandell C, Asplin G, Fagevik OM. The Swedish version of the pelvic girdle questionnaire, cross-cultural adaptation and validation. Disabil Rehabil. 2020;42:1013–20.CrossRef
20.
Zurück zum Zitat Acharya RS, Tveter AT, Grotle M, Khadgi B, Koju R, Eberhard-Gran M, et al. Cross-cultural adaptation and validation of the nepali version of the pelvic girdle questionnaire. J Manipulative Physiol Ther. 2020;43:257–65.CrossRef Acharya RS, Tveter AT, Grotle M, Khadgi B, Koju R, Eberhard-Gran M, et al. Cross-cultural adaptation and validation of the nepali version of the pelvic girdle questionnaire. J Manipulative Physiol Ther. 2020;43:257–65.CrossRef
21.
Zurück zum Zitat Gutke A, Boissonnault J, Brook G, Stuge B. The severity and impact of pelvic girdle pain and low-back pain in pregnancy: a multinational study. J Womens Health. 2018;27:510–7.CrossRef Gutke A, Boissonnault J, Brook G, Stuge B. The severity and impact of pelvic girdle pain and low-back pain in pregnancy: a multinational study. J Womens Health. 2018;27:510–7.CrossRef
22.
Zurück zum Zitat Grotle M, Garratt AM, Krogstad Jenssen H, Stuge B. Reliability and construct validity of self-report questionnaires for patients with pelvic girdle pain. Phys Ther. 2012;92:111–23.CrossRef Grotle M, Garratt AM, Krogstad Jenssen H, Stuge B. Reliability and construct validity of self-report questionnaires for patients with pelvic girdle pain. Phys Ther. 2012;92:111–23.CrossRef
23.
Zurück zum Zitat Wu J-M, Zhuo Y-Y, Qin X-L, Yu X-Y, Hu S, Ning Y. Pelvic-sacral tendon-regulation needling technique of acupuncture combined with manipulative reduction in treatment of postpartum pelvic girdle pain: a randomized controlled trial. Zhongguo Zhen Jiu. 2020;40:262–6.PubMed Wu J-M, Zhuo Y-Y, Qin X-L, Yu X-Y, Hu S, Ning Y. Pelvic-sacral tendon-regulation needling technique of acupuncture combined with manipulative reduction in treatment of postpartum pelvic girdle pain: a randomized controlled trial. Zhongguo Zhen Jiu. 2020;40:262–6.PubMed
24.
Zurück zum Zitat Vleeming A, Albert HB, Östgaard HC, Sturesson B, Stuge B. European guidelines for the diagnosis and treatment of pelvic girdle pain. Eur Spine J. 2008;17:794–819.CrossRef Vleeming A, Albert HB, Östgaard HC, Sturesson B, Stuge B. European guidelines for the diagnosis and treatment of pelvic girdle pain. Eur Spine J. 2008;17:794–819.CrossRef
25.
Zurück zum Zitat Fairbank JC, Pynsent PB. The Oswestry disability index. Spine. 2000;25:2940–53.CrossRef Fairbank JC, Pynsent PB. The Oswestry disability index. Spine. 2000;25:2940–53.CrossRef
26.
Zurück zum Zitat Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25:3186–91.CrossRef Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25:3186–91.CrossRef
27.
Zurück zum Zitat Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.CrossRef Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.CrossRef
28.
Zurück zum Zitat Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord. 2007;22:1901–11.CrossRef Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord. 2007;22:1901–11.CrossRef
29.
Zurück zum Zitat Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–45.CrossRef Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–45.CrossRef
30.
Zurück zum Zitat Haley SM, Fragala-Pinkham MA. Interpreting change scores of tests and measures used in physical therapy. Phys Ther. 2006;86:735–43.CrossRef Haley SM, Fragala-Pinkham MA. Interpreting change scores of tests and measures used in physical therapy. Phys Ther. 2006;86:735–43.CrossRef
31.
Zurück zum Zitat Acharya RS, Tveter AT, Grotle M, Eberhard-Gran M, Stuge B. Prevalence and severity of low back-and pelvic girdle pain in pregnant Nepalese women. BMC Pregnancy Childbirth. 2019;19:247.CrossRef Acharya RS, Tveter AT, Grotle M, Eberhard-Gran M, Stuge B. Prevalence and severity of low back-and pelvic girdle pain in pregnant Nepalese women. BMC Pregnancy Childbirth. 2019;19:247.CrossRef
32.
Zurück zum Zitat Close C, Sinclair M, Liddle D, Mc Cullough J, Hughes C. Women’s experience of low back and/or pelvic pain (LBPP) during pregnancy. Midwifery. 2016;37:1–8.CrossRef Close C, Sinclair M, Liddle D, Mc Cullough J, Hughes C. Women’s experience of low back and/or pelvic pain (LBPP) during pregnancy. Midwifery. 2016;37:1–8.CrossRef
33.
Zurück zum Zitat Bjelland EK, Eskild A, Johansen R, Eberhard-Gran M. Pelvic girdle pain in pregnancy: the impact of parity. Am J Obstet Gynecol. 2010;203:146.e1-146.e6.CrossRef Bjelland EK, Eskild A, Johansen R, Eberhard-Gran M. Pelvic girdle pain in pregnancy: the impact of parity. Am J Obstet Gynecol. 2010;203:146.e1-146.e6.CrossRef
34.
Zurück zum Zitat Shu X. Education and gender egalitarianism: the case of China. Sociol Educ. 2004;77:311–36.CrossRef Shu X. Education and gender egalitarianism: the case of China. Sociol Educ. 2004;77:311–36.CrossRef
Metadaten
Titel
Cross-cultural adaptation, reliability, and validity of a Chinese version of the pelvic girdle questionnaire
verfasst von
Hui Cong
Heng Liu
Yin Sun
Jinsong Gao
Juntao Liu
Liangkun Ma
Britt Stuge
Lixia Chen
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2021
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-021-03962-8

Weitere Artikel der Ausgabe 1/2021

BMC Pregnancy and Childbirth 1/2021 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.